SP1 and AL amyloidosis: In fact, miR-23b was found to directly suppress expression of transcription factor SP1 in multiple myeloma cells (68), and in gastric cancer, an inhibiting effect of miR-223 on epithelial to mesenchymal transition via direct posttranscriptional silencing of SP1 was reported (69).